OVERALL RESPONSE RATE OF PATIENTS WITH REFRACTORY MULTIPLE MYELOMA TREATED WITH POMALIDOMIDE AND LOW DOSE DEXAMETHASONE AFTER LENALIDOMIDE FAILURE: INTERIM RESULTS OF THE POSEIDON STUDY

被引：0
|
作者：
Dechow, T. [1 ]
Aldaoud, A. [2 ]
Hurtz, H. J. [3 ]
Knauf, W. [4 ]
Groschek, M. [5 ]
Hansen, R. [6 ]
Mittermueller, J.
Grebhardt, S. [7 ]
Boller, E. [7 ]
Potthoff, K. [7 ]
机构：
[1] Onkol Ravensburg, Ravensburg, Germany
[2] Gemeinschaftspraxis Hamatol & Onkol, Leipzig, Germany
[3] Onkol Gemeinschaftspraxis, Halle, Saale, Germany
[4] Onkol Gemeinschaftspraxis, Frankfurt, Germany
[5] Hamatol Onkol Stolberg, Stolberg, Germany
[6] Onkol Schwerpunktpraxis, Kaiserslautern, Germany
[7] iOMEDICO AG, Freiburg, Germany
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1304
引用
收藏
页码：540 / 540
页数：1
相关论文
共 50 条
  • [1] Pomalidomide plus low-dose dexamethasone in relapsed refractory multiple myeloma after lenalidomide treatment failure
    Siegel, David S.
    Schiller, Gary J.
    Song, Kevin W.
    Agajanian, Richy
    Stockerl-Goldstein, Keith
    Kaya, Hakan
    Sebag, Michael
    Samaras, Christy
    Malek, Ehsan
    Talamo, Giampaolo
    Seet, Christopher S.
    Mouro, Jorge
    Pierceall, William E.
    Zafar, Faiza
    Chung, Weiyuan
    Srinivasan, Shankar
    Agarwal, Amit
    Bahlis, Nizar J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 188 (04) : 501 - 510
  • [2] Identification of Novel Immune Cell Populations in Lenalidomide Refractory Relapsed Multiple Myeloma Patients Treated with Pomalidomide and Low Dose Dexamethasone
    Kalff, Anna
    Khong, Tiffany
    Ramachandran, Malarmathy
    Norton, Sam
    Mitchell, Andrew
    Reynolds, John
    Quach, Hang
    Ho, P. Joy
    Horvath, Noemi
    Mollee, Peter
    Kennedy, Nola
    Kemp, Roslyn
    Spencer, Andrew
    BLOOD, 2019, 134
  • [3] Elotuzumab In Combination with Lenalidomide and Low-Dose Dexamethasone In Patients with Relapsed/Refractory Multiple Myeloma: Interim Results of a Phase 1 Study
    Lonial, Sagar
    Vij, Ravi
    Harousseau, Jean-Luc
    Facon, Thierry
    Moreau, Philippe
    Leleu, Xavier
    Mazumder, Amitabha
    Kaufman, Jonathan L.
    Westland, Christopher E.
    Tsao, Claire
    Singhal, Anil K.
    Jagannath, Sundar
    BLOOD, 2010, 116 (21) : 805 - 806
  • [4] Phase 1/2 Study of Elotuzumab in Combination with Lenalidomide and Low Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma: Interim Results
    Lonial, Sagar
    Vij, Ravi
    Harousseau, Jean-Luc
    Facon, Thierry
    Kaufman, Jonathan
    Mazumder, Amitabha
    Moreau, Philippe
    Leleu, Xavier
    Fry, John
    Singhal, Anil
    Jagannath, Sundar
    BLOOD, 2009, 114 (22) : 179 - 180
  • [5] Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment
    David S. Siegel
    Gary J. Schiller
    Christy Samaras
    Michael Sebag
    Jesus Berdeja
    Siddhartha Ganguly
    Jeffrey Matous
    Kevin Song
    Christopher S. Seet
    Giampaolo Talamo
    Mirelis Acosta-Rivera
    Michael Bar
    Donald Quick
    Bertrand Anz
    Gustavo Fonseca
    Donna Reece
    William E. Pierceall
    Weiyuan Chung
    Faiza Zafar
    Amit Agarwal
    Nizar J. Bahlis
    Leukemia, 2020, 34 : 3286 - 3297
  • [6] Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment
    Siegel, David S.
    Schiller, Gary J.
    Samaras, Christy
    Sebag, Michael
    Berdeja, Jesus
    Ganguly, Siddhartha
    Matous, Jeffrey
    Song, Kevin
    Seet, Christopher S.
    Talamo, Giampaolo
    Acosta-Rivera, Mirelis
    Bar, Michael
    Quick, Donald
    Anz, Bertrand
    Fonseca, Gustavo
    Reece, Donna
    Pierceall, William E.
    Chung, Weiyuan
    Zafar, Faiza
    Agarwal, Amit
    Bahlis, Nizar J.
    LEUKEMIA, 2020, 34 (12) : 3286 - 3297
  • [7] Pomalidomide plus Low-Dose Dexamethasone plus Daratumumab in Relapsed and/or Refractory Multiple Myeloma after Lenalidomide-Based Treatment Failure
    Siegel, David S.
    Schiller, Gary J.
    Samaras, Christy J.
    Sebag, Michael
    Berdeja, Jesus G.
    Ganguly, Siddhartha
    Matous, Jeffrey V.
    Song, Kevin
    Seet, Christopher S.
    Talamo, Giampaolo
    Acosta-Rivera, Mirelis
    Bar, Michael
    Quick, Donald P.
    Anz, Bertrand
    Fonseca, Gustavo
    Reece, Donna
    Agarwal, Amit
    Chung, Weiyuan
    Zafar, Faiza
    Bahlis, Nizar
    BLOOD, 2018, 132
  • [8] Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma
    Paludo, Jonas
    Mikhael, Joseph R.
    LaPlant, Betsy R.
    Halvorson, Alese E.
    Kumar, Shaji
    Gertz, Morie A.
    Hayman, Suzanne R.
    Buadi, Francis K.
    Dispenzieri, Angela
    Lust, John A.
    Kapoor, Prashant
    Leung, Nelson
    Russell, Stephen J.
    Dingli, David
    Go, Ronald S.
    Lin, Yi
    Gonsalves, Wilson I.
    Fonseca, Rafael
    Bergsagel, P. Leif
    Roy, Vivek
    Sher, Taimur
    Chanan-Khan, Asher A.
    Ailawadhi, Sikander
    Stewart, A. Keith
    Reeder, Craig B.
    Richardson, Paul G.
    Rajkumar, S. Vincent
    Lacy, Martha Q.
    BLOOD, 2017, 130 (10) : 1198 - 1204
  • [9] OPTIMIZATION OF POMALIDOMIDE PLUS LOW DOSE DEXAMETHASONE IN REFRACTORY/RELAPSED MYELOMA MULTIPLE PATIENTS
    De Miguel, D.
    Gil, A.
    Golbano, N.
    Diaz, M.
    Guillen, H.
    Vazquez, A.
    Pinedo, B.
    HAEMATOLOGICA, 2017, 102 : 790 - 791
  • [10] Pomalidomide Plus Low Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World 'Powerful' Study
    Terpos, Evangelos
    Repousis, Panagiotis
    Lalayanni, Chrysavgi
    Hatjiharissi, Evdoxia
    Assimakopoulou, Theodora
    Vassilopoulos, George
    Pouli, Anastasia
    Spanoudakis, Emmanouil
    Michali, Evridiki
    Pangalis, Gerassimos
    Poziopoulos, Christos
    Kyrtsonis, Marie-Christine
    Pappa, Vassiliki
    Symeonidis, Argiris
    Georgopoulos, Christos
    Zikos, Panagiotis
    Papadaki, Helen A.
    Dadakaridou, Magda
    Karvounis-Marolachakis, Kiki
    Patos, Petros
    Katodritou, Eirini
    BLOOD, 2020, 136
12345